{"DataElement":{"publicId":"2656660","version":"1","preferredName":"AIDS Malignancy Consortium Patient Inclusion Clinical Trial Eligibility Criteria 048 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_I_CTEC_048_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518231","version":"1","preferredName":"AIDS Malignancy Consortium Patient Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_INCL_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC977E8-B49D-6863-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2656639","version":"1","preferredName":"048 Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility inclusion criteria for an AIDS Malignancy Consortium 048 protocol.","longName":"048_INCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Date informed consent obtained","valueDescription":"Date informed consent obtained","ValueMeaning":{"publicId":"2580745","version":"1","preferredName":"Date informed consent obtained","longName":"2580745","preferredDefinition":"Date informed consent obtained","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0876-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SHIDED","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"334219E4-E6E5-08E4-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SHIDED","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have a histologic diagnosis of Burkitt's lymphoma (BL) or atypical Burkitt's as per WHO criteria","valueDescription":"Does the participant have a histologic diagnosis of Burkitt's lymphoma (BL) or atypical Burkitt's as per WHO criteria","ValueMeaning":{"publicId":"2656645","version":"1","preferredName":"Does the participant have a histologic diagnosis of Burkitt's lymphoma (BL) or atypical Burkitt's as per WHO criteria","longName":"2656645","preferredDefinition":"Does the participant have a histologic diagnosis of Burkitt's lymphoma (BL) or atypical Burkitt's as per WHO criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33418232-A8E7-1A8F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-ADDA-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have normal baseline cardiac function based upon echocardiogram or multigated acquisition (MUGA) blood pool scan with an ejection fraction >=50%","valueDescription":"Does the participant have normal baseline cardiac function based upon echocardiogram or multigated acquisition (MUGA) blood pool scan with an ejection fraction >=50%","ValueMeaning":{"publicId":"2656644","version":"1","preferredName":"Does the participant have normal baseline cardiac function based upon echocardiogram or multigated acquisition (MUGA) blood pool scan with an ejection fraction >=50%","longName":"2656644","preferredDefinition":"Does the participant have normal baseline cardiac function based upon echocardiogram or multigated acquisition (MUGA) blood pool scan with an ejection fraction >=50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B6C5-F477-1BE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-ADEC-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have a serum creatinine <=1.5 mg/dL","valueDescription":"Does the participant have a serum creatinine <=1.5 mg/dL","ValueMeaning":{"publicId":"2656643","version":"1","preferredName":"Does the participant have a serum creatinine <=1.5 mg/dL","longName":"2656643","preferredDefinition":"Does the participant have a serum creatinine <=1.5 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B505-0C27-1AA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-ADFE-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"If the participant's creatinine is >1.5 mg/dL, is the creatinine clearance >=60 mL/minute","valueDescription":"If the participant's creatinine is >1.5 mg/dL, is the creatinine clearance >=60 mL/minute","ValueMeaning":{"publicId":"2656642","version":"1","preferredName":"If the participant's creatinine is >1.5 mg/dL, is the creatinine clearance >=60 mL/minute","longName":"2656642","preferredDefinition":"If the participant's creatinine is >1.5 mg/dL, is the creatinine clearance >=60 mL/minute","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B37B-3635-1955-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE10-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have ANC >=1000/uL and platelets >=50,000uL (unless disease-related)","valueDescription":"Does the participant have ANC >=1000/uL and platelets >=50,000uL (unless disease-related)","ValueMeaning":{"publicId":"2656641","version":"1","preferredName":"Does the participant have ANC >=1000/uL and platelets >=50,000uL (unless disease-related)","longName":"2656641","preferredDefinition":"Does the participant have ANC >=1000/uL and platelets >=50,000uL (unless disease-related)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B1A9-0D44-197D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE22-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have a direct bilirubin level of <=2.0 mg/dL","valueDescription":"Does the participant have a direct bilirubin level of <=2.0 mg/dL","ValueMeaning":{"publicId":"2656650","version":"1","preferredName":"Does the participant have a direct bilirubin level of <=2.0 mg/dL","longName":"2656650","preferredDefinition":"Does the participant have a direct bilirubin level of <=2.0 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341C4D3-693E-18D4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE34-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"If the elevated bilirubin is felt to be secondary to antiretroviral therapy, is the participant's total bilirubin <=3.5 mg/dL provided that the direct bilirubin is normal","valueDescription":"If the elevated bilirubin is felt to be secondary to antiretroviral therapy, is the participant's total bilirubin <=3.5 mg/dL provided that the direct bilirubin is normal","ValueMeaning":{"publicId":"2656649","version":"1","preferredName":"If the elevated bilirubin is felt to be secondary to antiretroviral therapy, is the participant's total bilirubin <=3.5 mg/dL provided that the direct bilirubin is normal","longName":"2656649","preferredDefinition":"If the elevated bilirubin is felt to be secondary to antiretroviral therapy, is the participant's total bilirubin <=3.5 mg/dL provided that the direct bilirubin is normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341C1D9-A07C-1B53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE46-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have AST (SGOT) and ALT (SGPT) <=3 x the upper limit of normal","valueDescription":"Does the participant have AST (SGOT) and ALT (SGPT) <=3 x the upper limit of normal","ValueMeaning":{"publicId":"2656648","version":"1","preferredName":"Does the participant have AST (SGOT) and ALT (SGPT) <=3 x the upper limit of normal","longName":"2656648","preferredDefinition":"Does the participant have AST (SGOT) and ALT (SGPT) <=3 x the upper limit of normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341C1D9-A06C-1B53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE58-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"If the participant is female, is she of childbearing age and using an acceptable form of birth control","valueDescription":"If the participant is female, is she of childbearing age and using an acceptable form of birth control","ValueMeaning":{"publicId":"2656647","version":"1","preferredName":"If the participant is female, is she of childbearing age and using an acceptable form of birth control","longName":"2656647","preferredDefinition":"If the participant is female, is she of childbearing age and using an acceptable form of birth control","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33418232-A8F7-1A8F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE6A-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"If the participant is female who is premenopausal, did she have a negative pregnancy test","valueDescription":"If the participant is female who is premenopausal, did she have a negative pregnancy test","ValueMeaning":{"publicId":"2656646","version":"1","preferredName":"If the participant is female who is premenopausal, did she have a negative pregnancy test","longName":"2656646","preferredDefinition":"If the participant is female who is premenopausal, did she have a negative pregnancy test","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B1A9-0D54-197D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341B8DF-AE7C-1686-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Is the participant HIV positive documented by enzyme-linked immunosorbent assay [ELISA] and Western Blot, or measurable HIV viral load","valueDescription":"Is the participant HIV positive documented by enzyme-linked immunosorbent assay [ELISA] and Western Blot, or measurable HIV viral load","ValueMeaning":{"publicId":"2656654","version":"1","preferredName":"Is the participant HIV positive documented by enzyme-linked immunosorbent assay [ELISA] and Western Blot, or measurable HIV viral load","longName":"2656654","preferredDefinition":"Is the participant HIV positive documented by enzyme-linked immunosorbent assay [ELISA] and Western Blot, or measurable HIV viral load","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341D2F3-BE7F-24B3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341D6BE-772C-20F5-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Is the participant (or their guardian) capable of providing informed consent","valueDescription":"Is the participant (or their guardian) capable of providing informed consent","ValueMeaning":{"publicId":"2656653","version":"1","preferredName":"Is the participant (or their guardian) capable of providing informed consent","longName":"2656653","preferredDefinition":"Is the participant (or their guardian) capable of providing informed consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341D1A5-5194-251E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341D6BE-773E-20F5-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Karnofsky performance status (must be >30%)","valueDescription":"Karnofsky performance status (must be >30%)","ValueMeaning":{"publicId":"2656652","version":"1","preferredName":"Karnofsky performance status (must be >30%)","longName":"2656652","preferredDefinition":"Karnofsky performance status (must be >30%)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B8DF-AE87-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341D6BE-7750-20F5-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Participant's age (in years)","valueDescription":"Participant's age (in years)","ValueMeaning":{"publicId":"2649471","version":"1","preferredName":"Participant's age (in years)","longName":"2649471","preferredDefinition":"Participant's age (in years)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"326557B2-97F1-3BD4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341D6BE-775C-20F5-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"},{"value":"Does the participant have measurable or non-measurable tumor parameter(s)","valueDescription":"Does the participant have measurable or nonmeasurable tumor parameter(s)","ValueMeaning":{"publicId":"2656651","version":"1","preferredName":"Does the participant have measurable or nonmeasurable tumor parameter(s)","longName":"2656651","preferredDefinition":"Does the participant have measurable or nonmeasurable tumor parameter(s)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B1A9-0D64-197D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3341D6BE-776D-20F5-E044-0003BA3F9857","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"ONEDATA","dateModified":"2007-06-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"334219E4-E6C6-08E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Inclusion Criteria","type":"Preferred Question Text","description":"Inclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3341B8DF-AE97-1686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-19","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}